AI-generated summary
The authors report a randomized clinical trial of photobiomodulation (red laser light) applied to the tongue in patients undergoing hematopoietic cell transplantation, compared with a placebo group. They report that the treatment was associated with fewer taste disturbances and less atrophy of the tongue papillae during the monitored periods. The abstract does not describe the certainty of these findings.
- Who or what was studied
- Adult patients undergoing hematopoietic cell transplantation, divided into a photobiomodulation group (n = 42) and a placebo group (n = 43)
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract does not describe limits of the study design, follow-up length, or certainty of the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 8.8 J/cm2
- Power
- 100 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.